Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Doyle-Lindrud

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Journal of Oncology Nursing|September 29, 2015
Proton beam therapy for pediatric malignanciesSusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|January 23, 2016
Telemedicine in OncologySusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|April 4, 2015
The evolution of the electronic health recordSusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|May 30, 2012
Managing side effects of the novel taxane cabazitaxel in castrate-resistant prostate cancerSusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|November 19, 2016
The MarginProbe® System: An Innovative Approach to Reduce the Incidence of Positive Margins Found After LumpectomySowsina Gola, Susan Doyle-Lindrud
Revista Latino-Americana De Enfermagem|July 25, 2019
Moving towards universal health coverage: advanced practice nurse competenciesJudy Honig, Susan Doyle-Lindrud, Jennifer Dohrn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 31, 2012
Transdermal estradiol in castrate and chemotherapy resistant prostate cancerMark Stein, Susan Goodin, Susan Doyle-Lindrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancerSusan Goodin, Patrick Medina, Terry Capanna, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancerSusan Goodin, Kamakshi V Rao, Michael Kane, et al.
The Prostate|September 25, 2004
A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancerKamakshi Rao, Susan Goodin, Michael J Levitt, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Journal of Oncology Nursing|September 29, 2015
Proton beam therapy for pediatric malignanciesSusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|January 23, 2016
Telemedicine in OncologySusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|April 4, 2015
The evolution of the electronic health recordSusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|May 30, 2012
Managing side effects of the novel taxane cabazitaxel in castrate-resistant prostate cancerSusan Doyle-Lindrud
Clinical Journal of Oncology Nursing|November 19, 2016
The MarginProbe® System: An Innovative Approach to Reduce the Incidence of Positive Margins Found After LumpectomySowsina Gola, Susan Doyle-Lindrud
Revista Latino-Americana De Enfermagem|July 25, 2019
Moving towards universal health coverage: advanced practice nurse competenciesJudy Honig, Susan Doyle-Lindrud, Jennifer Dohrn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 31, 2012
Transdermal estradiol in castrate and chemotherapy resistant prostate cancerMark Stein, Susan Goodin, Susan Doyle-Lindrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancerSusan Goodin, Patrick Medina, Terry Capanna, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancerSusan Goodin, Kamakshi V Rao, Michael Kane, et al.
The Prostate|September 25, 2004
A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancerKamakshi Rao, Susan Goodin, Michael J Levitt, et al.
Pageof 3